引用次数
引用: 2,813
H-指数: 28
I10-指数 : 46
出版物: 103
MAPK activation predicts poor survival after pancreatico-duodenectomy
M. M. Javle , J. Yu , M. Chadha , T. Khoury
Journal of Clinical Oncology 23 9578 -9578
2005
A structural and kinetic comparison of proto-oncogenic and oncogenic neu holo-receptors expressed in insect cells.
W. C. Dougall , C. M. LeVea , X. Qian , M. I. Greene
Receptor 3 ( 4) 293 -309
7
1993
Anti-receptor antibodies reverse the phenotype of cells transformed by two interacting proto-oncogene encoded receptor proteins.
V. I. Brown , C. M. LeVea , Jeffrey N Myers , M. I. Greene
Oncogene 5 ( 4) 489 -495
50
1990
Expression, purification, and characterization of Bacneu. A soluble protein tyrosine kinase domain encoded by the neu-oncogene.
M.I. Myers , J.N. , LeVea , C.M.
Receptor 2 ( 1) 1 -16
11
1992
Congenital Tuberculosis in a Neonatal Intensive Care Unit: Case Report, Epidemiological Investigation, and Management of Exposures
L. H. Lee , C. M. LeVea , P. S. Graman
Clinical Infectious Diseases 27 ( 3) 474 -477
64
1998
A phase I pharmacokinetic (PK) study of vorinostat (V) in combination with irinotecan (I), 5-fluorouracil (5FU), and leucovorin (FOLFIRI) in advanced upper gastrointestinal cancers (AGC)
G. J. Fetterly , W. E. Brady , C. M. LeVea , A. M. Litwin
Journal of Clinical Oncology 27
7
2009
Ligand and p185c-neu density govern receptor interactions and tyrosine kinase activation.
A. Samanta , C. M. LeVea , W. C. Dougall , X. Qian
Proceedings of the National Academy of Sciences of the United States of America 91 ( 5) 1711 -1715
95
1994
Heterodimerization of epidermal growth factor receptor and wild-type or kinase-deficient Neu: a mechanism of interreceptor kinase activation and transphosphorylation.
X. Qian , C. M. LeVea , J. K. Freeman , W. C. Dougall
Proceedings of the National Academy of Sciences of the United States of America 91 ( 4) 1500 -1504
142
1994
EGF-dependent cell cycle progression is controlled by density-dependent regulation of Akt activation.
C.M LeVea , J.E Reeder , R.A Mooney
Experimental Cell Research 297 ( 1) 272 -284
15
2004
Conditional deletion of p53 and Rb in the renin-expressing compartment of the pancreas leads to a highly penetrant metastatic pancreatic neuroendocrine carcinoma.
C A Jones , S Sexton , C M LeVea , S M Caraker
Oncogene 33 ( 50) 5706 -5715
23
2014
Expression of the leucocyte common antigen-related (LAR) tyrosine phosphatase is regulated by cell density through functional E-cadherin complexes.
Javelle R. SYMONS , Charles M. LeVEA , Robert A. MOONEY
Biochemical Journal 365 ( 2) 513 -519
27
2002
Breast cancer resistance protein (BCRP) and excision repair cross complement-1 (ERCC1) expression in esophageal cancers and response to cisplatin and irinotecan based chemotherapy
Terry L. Mashtare , Anubha Bharthuar , Renuka Iyer , Jennifer D. Black
Journal of gastrointestinal oncology 5 ( 4) 253 -258
8
2014
Spontaneous regression of colorectal cancer metastatic to retroperitoneal lymph nodes.
Ahmad A. Fora , Charles Levea , Arvinder S. Bir , Marwan G. Fakih
Anticancer Research 29 ( 2) 465 -468
17
2009
Gastrointestinal Stromal Tumor: Chondro-Myxoid Variant Mimicking Chondrosarcoma
Ashwani Rajput , Charles Levea , Marilyn Intengan , John Kane
Sarcoma 9 25 -28
1
2005
Engraftment of resected pancreatic adenocarcinoma in SCID mice and patient survival following surgical resection: Roswell Park's experience.
Elizabeth S Repasky , Wen Wee Ma , Jose Luis Aranez , Potjana Jitawatanarat
Journal of Clinical Oncology 32 185 -185
2014
Utilizing Ki67 score to predict optimal liver-directed treatment in patients with metastatic neuroendocrine tumors.
Smit Singla , Kristopher Attwood , Charles Levea , Garin Tomaszewski
Journal of Clinical Oncology 33 370 -370
2015
Surgical Resection after TNFerade TM Therapy for Locally Advanced Pancreatic Cancer
Manpreet K Chadha , Alan Litwin , Charles Levea , Renuka Iyer
JOP. J Pancreas (Online) 10 ( 5) 535 -538
9
2009
RON tyrosine kinase: A potential target for colorectal cancer therapy
Ashwani Rajput , Rebecca Rose , Charles Levea , Alexander Beko
Cancer Research 66 ( 8_Supplement) 633 -633
1
2006
Tu1642 Outcomes of Endoscopic Resection for High Grade Dysplasia and Esophageal Cancer
Steven Nurkin , Hector R. Nava , Sai Yendamuri , Charles M. Levea
Gastrointestinal Endoscopy 75 ( 4)
1
2012
Enhanced FGFR signalling predisposes pancreatic cancer to the effect of a potent FGFR inhibitor in preclinical models
H Zhang , BL Hylander , C LeVea , EA Repasky
British Journal of Cancer 110 ( 2) 320 -329
29
2014